| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.75B | $1.50B | $1.43B |
| YoY Revenue Growth % | +16.6% | +4.5% | — |
| Gross Profit | $1.32B | $1.11B | — |
| Gross Margin % | 75.9% | 73.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $263.1M | $123.9M | $81.0M |
| Operating Margin % | 15.1% | 8.3% | 5.7% |
| Net Income (GAAP) | $393.4M | $99.2M | $67.8M |
| EBITDA (Normalized) | $274.7M | $130.1M | $132.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $505.2M | $345.9M | $217.8M |
| Capital Expenditures (CapEx) | $14.5M | $7.7M | $64.5M |
| Free Cash Flow (FCF) | $490.7M | $338.2M | $153.3M |
| FCF Margin % | 28.1% | 22.6% | 10.7% |
| Return on Invested Capital (ROIC %) | 21.8% | 12.5% | 3.4% |
| Cash & Short-Term Equivalents | $212.4M | $337.1M | — |
| Total Debt (Short + Long Term) | $380.0M | $532.3M | $718.5M |
| Total Stockholders' Equity | $787.4M | $585.5M | $1.47B |